Enzymotec to Host a VAYA Pharma Analyst and Investor Day in New York City on November 19, 2015
2015年11月10日 - 10:30PM
Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid-based nutritional
ingredients and medical foods, today announced that the Company
will host a VAYA Pharma Analyst and Investor Day at Four Times
Square in New York City on November 19, 2015, beginning at 12pm ET.
The meeting will feature presentations from VAYA Pharma's Chief
Executive Officer, Rob Crim, and its executive team on VAYA
Pharma's growth strategies, research and development and marketing
programs.
Enzymotec will host a live webcast of the event at
www.enzymotec.com. The webcast and related presentation materials
will also be archived on the website.
Prior registration is required with The Ruth Group.
About VAYA Pharma
VAYA Pharma is a specialty pharmaceutical division of Enzymotec
Ltd. dedicated to the discovery, development, manufacture and
marketing of innovative lipid-based compositions familiar to the
human body for addressing disorders that are impacted by lipid
imbalances.
VAYA Pharma's medical food portfolio addresses three therapeutic
segments: ADHD (Vayarin(R)), Early Memory Impairment (Vayacog(R))
and Hypertriglyceridemia (Vayarol(R)). VAYA Pharma products are
available in the U.S. only by prescription under the supervision of
a physician. VAYA Pharma USA is headquartered in Baltimore,
Maryland. For more information, visit www.vayapharma.com
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies. For more information, visit www.enzymotec.com.
CONTACT: The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
tbui@theruthgroup.com
lroth@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 6 2024 まで 7 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (ナスダック市場): 0 recent articles
その他のニュース記事